Today: 19 May 2026
UK Stock Market Today: FTSE 100 Steadies Near Flat as AI Jitters Drag RELX

UK Stock Market Today: FTSE 100 Steadies Near Flat as AI Jitters Drag RELX

London, February 6, 2026, 10:47 GMT — Regular session

UK shares barely moved on Friday, held back by drops in data and software stocks. The FTSE 100 edged up just 0.01% to 10,310.70 by 10:47 GMT, while the FTSE 250 slipped 0.06% to 23,088.74.

That calm didn’t last long. Thursday’s razor-thin Bank of England vote sent sterling and UK government bonds reeling, reviving speculation about rate cuts. “The vote split is a lot more dovish than expected,” said Kirstine Kundby-Nielsen, an analyst at Danske Bank. Reuters

The Bank kept its key rate steady at 3.75% but hinted at possible cuts if inflation continues to fall, pushing traders to price in an earlier easing cycle. This move comes as investors worldwide rethink the winners and losers from rapid AI advances, a trend now influencing London’s large-cap stocks.

RELX dropped 4.2% to 2,155.00 pence, topping the FTSE 100 fallers. Sage Group slipped 2.8%, and Entain was down 2.9%. These declines deepened worries around firms vulnerable to AI-driven disruption in data, analytics, and software.

Miners and banks provided some support. Glencore edged up 1.3% to 481.35 pence, with Fresnillo rising 1.5% to 3,611.00 pence. On the banking front, Barclays gained 1.3% to 472.32 pence, and NatWest ticked up 0.8% to 655.30 pence.

Thursday’s close stayed above the tape. The FTSE 100 slipped 0.9% as a split vote at the Bank raised bets on more rate cuts, dragging banks down; HSBC, Lloyds, and NatWest shed between 2.3% and 6%. Shell tumbled 3.4% after missing fourth-quarter profit estimates, while Rio Tinto and Glencore slipped following the collapse of their merger talks.

Housing data offered a fresh take on rate sensitivity. Halifax reported a 0.7% jump in house prices for January, rebounding from a 0.5% drop in December and pushing the average past the £300,000 mark for the first time. “Affordability remains a challenge,” noted Amanda Bryden, Halifax’s head of mortgages. Ashley Webb, an economist at Capital Economics, warned that political instability could push gilt yields higher — the return on UK government bonds — potentially slowing any decline in mortgage rates. Reuters

Friday’s session kicked off on a down note, dragged by renewed jitters over AI spending and its disruptive impact. “It’s just another day… another pledge to invest massively in AI… and another negative market reaction,” said Swissquote analyst Ipek Ozkardeskaya. Among mid-caps, HgCapital Trust surged after an update, while Victrex slipped following a trading statement; CEO James Routh insisted the “full year guidance remains unchanged.” shareprices.com

The biggest risks remain mostly under the radar: the global software sector has plunged into what some traders call a sentiment washout, erasing about $1 trillion from U.S. software and services since late January, Reuters reported. “At this stage, I’d say it’s a sell-everything mood,” said Dave Harrison Smith, chief investment officer at Bailard. Reuters

Investors are now focused on the rescheduled U.S. January jobs report set for February 11 at 8:30 a.m. ET, delayed by the partial government shutdown. Across the pond, the Bank of England’s next rate decision comes on March 19, a key date in the ongoing discussion over potential cuts.

Stock Market Today

  • Palatin Technologies to Start Trading on Nasdaq Capital Market May 29, 2026
    May 18, 2026, 10:37 PM EDT. Palatin Technologies, Inc. (NYSE American: PTN) announced the transfer of its stock listing to the Nasdaq Capital Market, effective May 29, 2026, continuing under the symbol 'PTN.' The move from NYSE American aims to increase stock visibility and liquidity, and attract institutional investors. Palatin is developing MC4R-targeted therapies for rare obesity disorders, including hypothalamic obesity and Prader-Willi syndrome, with key drug candidates nearing regulatory submission in late 2026 and early 2027. CEO Carl Spana highlighted the strategic benefits of joining the Nasdaq biotechnology community to advance the company's clinical and commercial goals.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.
Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan
Previous Story

Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan

Gold price rebounds after violent selloff as traders brace for more volatility
Next Story

Gold price rebounds after violent selloff as traders brace for more volatility

Go toTop